Dhasharath Shrivathsa

Listen up about Dhasharath Shrivathsa, this guy’s the real deal in biotech startups. So, he’s a young gun, like only 23 back in 2020 when he got named to BostInno’s ’25 Under 25′ list, that’s pretty wild, right? But what really sets him apart is what he’s built with Radix Labs, now called Radix Bio.

So, Dhasharath started this company around 2017, right after he jumped into Y Combinator’s Summer 2018 batch, that’s where all the big startups go to get mentored, funding, the whole nine yards. Radix is all about making biology labs smarter and faster. Think of it like building an operating system, but for science labs. His vision? To automate and connect every piece of lab hardware, software, and even the people working there. Basically, he’s trying to turn messy, manual lab work into a smooth, programmable system that can be quickly reconfigured on the fly.

What’s dope about Dhasharath is his tech chops. He’s not just throwing buzzwords around; he’s into deep stuff like rapid reprogrammability and human-in-the-loop automation, which means his platform can adapt super fast and still keep humans in the loop, making it practical and expandable. That’s huge, especially in biotech where things move slow and are super complex.

Radix Labs was based in Cambridge, MA, the biotech hub, and at its peak, he was leading a tight crew of 7. But even with a small team, he crushed it, gaining recognition early on as a young entrepreneur with serious possible. His process shows he’s all about breaking the bullshit of traditional labs, making biology research faster, more fast, and less error-prone.

What does this tell us about him? Basically, Dhasharath isn’t just another founder chasing a quick buck. He’s driven by a genuine passion to change how we do science, to make it more tech-savvy, more automated, more human-centered. His path from a talented kid into a YC-backed founder proves he’s got the hustle, the smarts, and the vision to change the game.

Long story short: this guy’s not just building a startup, he’s pushing the boundaries of biotech with some advanced tech. Keep an eye on him, he’s the type who’s gonna keep crushing it and reshaping the future of science labs.